HOUSTON–(Oct. 19, 2016)–Researchers at Houston Methodist kept mice from getting the flu by removing a gene that regulates their immune system. According to a study recently published in Nature Immunology (online Oct. 3), mice missing the gene Trim29 eliminated human influenza virus within 48 hours, protecting them from infection.
HOUSTON-(Oct. 11, 2016)–Scientists at Houston Methodist received support from the U.S. Department of Defense (DoD) to reprogram immune cells to attack triple negative breast cancer, the most lethal form of the disease. The DoD awarded Rongfu Wang, Ph.D., director of the Center for Inflammation & Epigenetics at Houston Methodist Research Institute, $3 million to create a personalized vaccine that retrains cancer patients’ immune systems to safely target and eliminate breast tumors and spare normal tissue.
Houston Methodist received $9 million from the National Cancer Institute to establish the Center for Immunotherapeutic Transport Oncophysics (CITO). CITO combines the studies of cancer immunology, nanotechnology and the physics of cancer biology. CITO will focus on using research information to design immunotherapies for breast and pancreatic cancers.
A stranger started a chain of events that led to six people receiving new kidneys at one institution.
Texas A&M University is planning to create an innovative engineering medical school at Houston Methodist Hospital to educate a new kind of doctor, pending appropriate approvals, who will invent transformational technology for health care, officials announced today.
Chronic use of some drugs for heartburn and gastroesophageal reflux (GERD) speeds up the aging of blood vessels, according to a published paper in Circulation Research (early online), an American Heart Association journal. This accelerated aging in humans could lead to increased cardiovascular disease, vascular dementia and renal failure.
Screening women for osteoporosis is now routine, however, when it comes to men, most are never screened and therefore suffer the consequences of the disease. In the U.S., nearly 1.5 million men over 65 have osteoporosis, and another 3.5 million men are at risk for developing the disease.
Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.
The Houston Methodist Research Institute’s newly created Center of Space Nanomedicine is working with the Center for the Advancement of Science in Space (CASIS) to send eight experiments to the International Space Station (ISS) over the next five years. The first experiment is set for launch this week.
Allergy season can be the worst time of year for people suffering with restless legs syndrome because popular over the counter medications can make symptoms much worse.
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology (early online edition).
Neurosurgeons at Houston Methodist Hospital report the successful treatment of deep-seated thalamic and brain stem cavernous angiomas in an upcoming article in the Journal of Neurosurgery (online March 8).
Many patients showing signs of dementia are quickly diagnosed with Alzheimer’s disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
A new study will evaluate the use of whole umbilical cord blood to help the brain heal quicker after an ischemic stroke.
Chemotherapy treatment is a necessary evil in the fight against most cancers and has prolonged life for millions of people. However, many cancer survivors suffer from an increased risk of heart problems related to the toxic effect some chemotherapy drugs have on the heart. The key is catching it early.
More than 120,000 people are currently on the kidney transplant waiting list, some waiting anywhere from four to six years. Some of those people will die before the new kidney comes. Asking a family member or friend to donate a kidney might be difficult, but it has many advantages without affecting the donor.
Many people fall off ladders when putting up holiday lights and severely damage their feet.
Marc Garbey, Ph.D., has joined Houston Methodist as scientific director of the Center for Computational Surgery. He was previously professor in the Department of Computer Science and the Department of Biology and Biochemistry at the University of Houston.
Many people will use caffeine to give them the extra boost they need to get everything done for the holiday season. However, a Houston Methodist internist says the need for more caffeine might be masking some serious sleep problems.
Most of us will seriously overeat between Thanksgiving and New Year's Day. Those people walking around with non-alcoholic fatty liver disease could make the condition a lot worse, opening them up to serious diseases.
The National Cancer Institute awarded Houston Methodist investigator Randa El-Zein, M.B., Ch.B., Ph.D., a $2.8 million, five-year U01 grant to combine mammography features with blood-based biomarkers to more precisely predict a woman’s risk for breast cancer-specific subtypes.
Women put so much stress on themselves to make everything perfect for everything. This unnecessary pressure is not good for their heart health.
The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical trial that looks at removing a key protein from the brain to prevent memory loss at least a decade before symptoms are noticed in healthy older adults.
Researchers at Houston Methodist, along with collaborators at two major Singapore institutions, have developed a lab in a needle device that could provide instant results to routine lab tests, accelerating treatment and diagnosis by days.
The National Cancer Institute awarded Houston Methodist and Weill Cornell a multi-million dollar U01 grant to identify non-small cell lung cancer (NSCLC) therapy targets critical to identifying how tumors interact with surrounding cells.
The Houston Methodist Neurological Institute's new Center for Neuroregenerative Medicine scientific director is Philip Horner, Ph.D., an expert on the use of stem cells to replace damaged brain and spinal cord tissue.
As the Fourth of July quickly approaches, people are preparing delicious side dishes to take to backyard cookouts. Unfortunately, these high-calorie side dishes can create a challenge for people who want to maintain or lose weight while still enjoying summer festivities.
Adults who use proton pump inhibitors are between 16 and 21 percent more likely to experience a heart attack than people who don't use the commonly prescribed antacid drugs, according to a massive new study by Houston Methodist and Stanford University scientists.
Surgical teams from Houston Methodist Hospital and The University of Texas MD Anderson Cancer Center successfully transplanted, for the first time, a scalp and skull while performing kidney and pancreas transplants.
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports.
A http:team of international scientists has identified hundreds of possible new genes in mice that could transform benign skin growths into deadly melanomas.
Researchers at Houston Methodist have invented a new, ex vivo lung cancer model that mimics the process of tumor progression. Tests of the model are published this month in The Annals of Thoracic Surgery (now online).
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
A new clip helps older patients with mitral valve prolapse and who are not strong enough for open surgery.
Scientists say they know how white adipose cells -- often called "bad fat" -- can be converted into "good," brown adipose in mice using little more than a synthetic stand-in for thyroid hormone.
Rice University catcher, John Clay Reeves, felt pain in his groin after a collision at the plate with an opposing player. He thought he had pulled a muscle, but it turns out he was suffering from a common condition seen in teens and young adults known as hip impingement.
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique.
Increased awareness of the importance of digestive health has quickly turned into a multi-million dollar industry. According to Global Industry Analysts, the probiotics market is expected to exceed $29 billion by 2015 and expected to rise 7 percent a year over the next five years.
Overindulging at a holiday party or two this season isn’t going make a big difference in someone’s health. But it could be a much different story for people with type 2 diabetes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right